Stress, Anxiety, and Mood Group Therapy
| Status: | Recruiting |
|---|---|
| Conditions: | Anxiety, Depression, Depression |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 50 |
| Updated: | 3/1/2019 |
| Start Date: | February 2019 |
| End Date: | February 2020 |
| Contact: | Stacie Warren, PhD |
| Email: | swarren@paloaltou.edu |
| Phone: | 650-417-2038 |
Transdiagnostic Interventions for Emotional Disorders
The purpose of this study is to identify cognitive mechanisms that might facilitate treatment
response for individuals experiencing depression and/or anxiety. The Stress, Anxiety, and
Mood group helps individuals experiencing symptoms of stress, anxiety, and mood by providing
concrete coping skills to regulate emotions, to let go of negative thoughts, and build
courage to talk to others about tough topics. Groups meet for 8 weeks, with sessions lasting
90 minutes each. In addition to group therapy, you will be asked to complete some
computerized and paper and pencil-based tasks.
If you are interested in learning more, please contact us at 650-417-2000 ext. 3642 or
paloalto.study@gmail.com. All inquiries will be kept strictly confidential.
response for individuals experiencing depression and/or anxiety. The Stress, Anxiety, and
Mood group helps individuals experiencing symptoms of stress, anxiety, and mood by providing
concrete coping skills to regulate emotions, to let go of negative thoughts, and build
courage to talk to others about tough topics. Groups meet for 8 weeks, with sessions lasting
90 minutes each. In addition to group therapy, you will be asked to complete some
computerized and paper and pencil-based tasks.
If you are interested in learning more, please contact us at 650-417-2000 ext. 3642 or
paloalto.study@gmail.com. All inquiries will be kept strictly confidential.
PRIMARY OBJECTIVES:
I. Identify specific patterns of executive function impairment that distinguish affective and
cognitive symptoms in anxious and/or depressed patients.
II. Identify specific components of executive function that predict Unified Protocol
treatment response. This will set up subsequent cognitive intervention studies targeting
those components.
The phone screen includes a confidentiality statement explaining how their information will
be kept confidential, demographic questions, and questions regarding the participants'
medical and psychiatric history, and current psychological state. Responses to these
questions will be used to determine if the individual meets inclusion criteria to engage in
the study. If the participant meets study eligibility criteria, he/she will be invited to an
informational session not exceeding two and a half hours at Dr. Warren's lab, which involves
an explanation the project, informed consent, some questionnaires, and a diagnostic clinical
interview. Also during the first visit, participants will be informed of the upcoming visits
and the types of activities they will be asked to engage in for the purposes of this study.
During a second visit, subjects will undergo cognitive testing designed to measure set
shifting, working memory updating, cognitive inhibition, processing speed, general
intelligence, and attentional control. These tests will be administered at Dr. Warren's lab
and will not exceed two and a half hours. The remainder of the study visits will involve an
8-week, cognitive-behavioral group therapy titled "Unified Protocol," to take place at the
Gronowski Clinic. Treatment groups will be facilitated by Dr. Warren and co-facilitated by
trained graduate students selected by Dr. Warren.
I. Identify specific patterns of executive function impairment that distinguish affective and
cognitive symptoms in anxious and/or depressed patients.
II. Identify specific components of executive function that predict Unified Protocol
treatment response. This will set up subsequent cognitive intervention studies targeting
those components.
The phone screen includes a confidentiality statement explaining how their information will
be kept confidential, demographic questions, and questions regarding the participants'
medical and psychiatric history, and current psychological state. Responses to these
questions will be used to determine if the individual meets inclusion criteria to engage in
the study. If the participant meets study eligibility criteria, he/she will be invited to an
informational session not exceeding two and a half hours at Dr. Warren's lab, which involves
an explanation the project, informed consent, some questionnaires, and a diagnostic clinical
interview. Also during the first visit, participants will be informed of the upcoming visits
and the types of activities they will be asked to engage in for the purposes of this study.
During a second visit, subjects will undergo cognitive testing designed to measure set
shifting, working memory updating, cognitive inhibition, processing speed, general
intelligence, and attentional control. These tests will be administered at Dr. Warren's lab
and will not exceed two and a half hours. The remainder of the study visits will involve an
8-week, cognitive-behavioral group therapy titled "Unified Protocol," to take place at the
Gronowski Clinic. Treatment groups will be facilitated by Dr. Warren and co-facilitated by
trained graduate students selected by Dr. Warren.
Inclusion Criteria:
- Normal color vision
- Ability to travel to Palo Alto University
- Experiencing symptoms of stress, anxiety, and/or depression
We found this trial at
1
site
Click here to add this to my saved trials
